During the past decade, Réanimation médicale conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Réanimation médicale" are "COVID19" (1 trials), "Patients Died in Intensive Care Unit (ICU)" (1 trials) and "SARS-CoV-2" (1 trials). Many other conditions were trialed in "Réanimation médicale" in a lesser frequency.

Most popular intervention types in "Réanimation médicale" are "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Eculizumab" (1 trials) and "Improving communication during the end-of-life process" (1 trials). Other intervention names were less common.

The vast majority of trials in "Réanimation médicale" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Réanimation médicale". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Réanimation médicale, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Réanimation médicale, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".